SALIX PHARMACEUTICALS LTD Revenue
SALIX PHARMACEUTICALS LTD reported Revenue of $13.48 million for the 3-month period ending 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2015-03-02
- SALIX PHARMACEUTICALS LTD revenues for the quarter ending 2014-12-31 was $13.48M, a 94.33% decline year-over-year.
- SALIX PHARMACEUTICALS LTD revenues for the quarter ending 2014-09-30 was $354.72M, a 48.93% increase year-over-year.
- SALIX PHARMACEUTICALS LTD revenues for the quarter ending 2014-06-30 was $375.54M, a 59.50% increase year-over-year.
- SALIX PHARMACEUTICALS LTD revenues for the quarter ending 2014-03-31 was $402.98M, a 98.90% increase year-over-year.
- SALIX PHARMACEUTICALS LTD revenues for fiscal 2014 was $1.13B, a 24.05% increase from fiscal 2013.
- SALIX PHARMACEUTICALS LTD revenues for fiscal 2013 was $913.78M, a 24.25% increase from fiscal 2012.
- SALIX PHARMACEUTICALS LTD revenues for fiscal 2012 was $735.44M, a 36.07% increase from fiscal 2011.
- SALIX PHARMACEUTICALS LTD revenues for fiscal 2011 was $540.49M, a 60.40% increase from fiscal 2010.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | $13.48M 10-K · filed 2015-03-02 | $355.02M derived: sum of 2 quarters · filed 2015-03-02 | $730.56M derived: sum of 3 quarters · filed 2015-03-02 | $1.13B 10-K · filed 2015-03-02 | ||||
| 2014-09-30 | $354.72M 10-Q · filed 2014-11-07 | $717.09M derived: sum of 2 quarters · filed 2015-03-02 | $1.12B 10-Q/A · filed 2015-03-02 | $1.12B 10-Q · filed 2014-11-07 | $1.36B derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2014-06-30 | $375.54M 10-Q/A · filed 2015-03-02 | $382.00M 10-Q · filed 2014-08-08 | $778.52M 10-Q/A · filed 2015-03-02 | $766.37M 10-Q · filed 2014-08-08 | $1.02B derived: sum of 3 quarters · filed 2015-03-02 | $1.25B derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2014-03-31 | $402.98M 10-Q/A · filed 2015-03-02 | $384.37M 10-Q · filed 2014-05-09 | $640.53M derived: sum of 2 quarters · filed 2015-03-02 | $878.72M derived: sum of 3 quarters · filed 2015-03-02 | $1.11B derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-12-31 | $237.56M 10-K · filed 2015-03-02 | $257.61M 10-K · filed 2014-02-28 | $475.74M derived: sum of 2 quarters · filed 2015-03-02 | $711.18M derived: sum of 3 quarters · filed 2015-03-02 | $913.78M 10-K · filed 2015-03-02 | $933.84M 10-K · filed 2014-02-28 | ||
| 2013-09-30 | $238.18M 10-K · filed 2015-03-02 | $473.63M derived: sum of 2 quarters · filed 2015-03-02 | $676.23M 10-Q/A · filed 2015-03-02 | $874.40M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | $235.44M 10-K · filed 2015-03-02 | $438.04M 10-Q/A · filed 2015-03-02 | $636.22M derived: sum of 3 quarters · filed 2015-03-02 | $821.35M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | $202.60M 10-K · filed 2015-03-02 | $400.77M derived: sum of 2 quarters · filed 2015-03-02 | $585.91M derived: sum of 3 quarters · filed 2015-03-02 | $757.04M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $198.17M 10-K · filed 2015-03-02 | $383.31M derived: sum of 2 quarters · filed 2015-03-02 | $554.44M derived: sum of 3 quarters · filed 2015-03-02 | $735.44M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | $185.13M 10-K · filed 2015-03-02 | $356.26M derived: sum of 2 quarters · filed 2015-03-02 | $537.27M 10-Q · filed 2013-11-08 | $692.45M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-06-30 | $171.13M 10-K · filed 2015-03-02 | $181.01M 10-Q · filed 2012-08-09 | $352.14M 10-Q · filed 2013-08-09 | $507.32M derived: sum of 3 quarters · filed 2015-03-02 | $653.57M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2012-03-31 | $181.01M 10-K · filed 2015-03-02 | $171.13M 10-Q · filed 2012-05-08 | $336.19M derived: sum of 2 quarters · filed 2015-03-02 | $482.44M derived: sum of 3 quarters · filed 2015-03-02 | $615.60M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2011-12-31 | $155.18M 10-K · filed 2013-03-01 | $301.43M derived: sum of 2 quarters · filed 2013-03-01 | $434.59M derived: sum of 3 quarters · filed 2013-03-01 | $540.49M 10-K · filed 2015-03-02 | ||||
| 2011-09-30 | $146.25M 10-K · filed 2013-03-01 | $279.41M derived: sum of 2 quarters · filed 2013-03-01 | $385.31M 10-Q · filed 2012-11-08 | $503.80M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | $133.16M 10-K · filed 2013-03-01 | $239.06M 10-Q · filed 2012-08-09 | $357.56M derived: sum of 3 quarters · filed 2013-03-01 | $438.18M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | $105.90M 10-K · filed 2013-03-01 | $224.40M derived: sum of 2 quarters · filed 2013-03-01 | $305.02M derived: sum of 3 quarters · filed 2013-03-01 | $398.79M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2010-12-31 | $118.50M 10-K · filed 2012-02-28 | $199.12M derived: sum of 2 quarters · filed 2012-02-28 | $292.90M derived: sum of 3 quarters · filed 2012-02-28 | $336.97M 10-K · filed 2013-03-01 | ||||
| 2010-09-30 | $80.63M 10-K · filed 2012-02-28 | $174.40M derived: sum of 2 quarters · filed 2012-02-28 | $218.47M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $93.77M 10-K · filed 2012-02-28 | $137.85M 10-Q · filed 2011-08-09 | ||||||
| 2010-03-31 | $44.08M 10-K · filed 2012-02-28 | |||||||
| 2009-12-31 | $232.89M 10-K · filed 2012-02-28 |